Sale!

CLPB Gene 3-Methylglutaconic Aciduria Type 7 with Cataracts Neurologic Involvement and Neutropenia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLPB gene test for 3-Methylglutaconic Aciduria Type 7 with Cataracts, Neurologic Involvement, and Neutropenia is a genetic examination aimed at identifying mutations in the CLPB gene, which are associated with a rare metabolic disorder. This condition is characterized by a spectrum of symptoms including elevated levels of 3-methylglutaconic acid in the urine, development of cataracts, various neurological issues, and a reduction in neutrophils, a type of white blood cell crucial for fighting infections. The genetic test is a crucial tool for diagnosing this condition, enabling healthcare providers to tailor treatment and management strategies for affected individuals.

The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the examination and the sophisticated technology employed in identifying the genetic mutation responsible for this condition. Early diagnosis through this test can significantly improve the quality of life for patients by facilitating timely interventions and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLPB Gene 3-methylglutaconic aciduria type 7 with cataracts neurologic involvement and neutropenia Genetic Test

Test Name: CLPB Gene 3-methylglutaconic aciduria type 7 with cataracts neurologic involvement and neutropenia Genetic Test

Components: Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CLPB Gene 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia.

Test Details: The CLPB gene is associated with a rare genetic disorder called 3-methylglutaconic aciduria type 7. This disorder is characterized by the presence of cataracts, neurologic involvement, and neutropenia (low levels of neutrophils, a type of white blood cell). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the case of 3-methylglutaconic aciduria type 7, NGS genetic testing can be used to identify mutations or variations in the CLPB gene that are responsible for the disorder. By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic changes present in the CLPB gene, helping to confirm a diagnosis of 3-methylglutaconic aciduria type 7. This information can also be used for genetic counseling and to guide potential treatment options for the patient.

Test Name CLPB Gene 3-methylglutaconic aciduria type 7 with cataracts neurologic involvement and neutropenia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLPB Gene 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia
Test Details

The CLPB gene is associated with a rare genetic disorder called 3-methylglutaconic aciduria type 7. This disorder is characterized by the presence of cataracts, neurologic involvement, and neutropenia (low levels of neutrophils, a type of white blood cell).

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the case of 3-methylglutaconic aciduria type 7, NGS genetic testing can be used to identify mutations or variations in the CLPB gene that are responsible for the disorder.

By analyzing the patient’s DNA, NGS genetic testing can provide valuable information about the specific genetic changes present in the CLPB gene, helping to confirm a diagnosis of 3-methylglutaconic aciduria type 7. This information can also be used for genetic counseling and to guide potential treatment options for the patient.